Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study
{{output}}
Objective: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative method for treating myelodysplastic syndrome (MDS). Post-HSCT measurable residual disease (post-HSCT MRD) is associated wi... ...
